A message from Kalderos founder and CEO Jeremy Docken
For the release of our first-ever Annual Report, Kalderos founder and CEO Jeremy Docken shares his thoughts on not only the substance of this report, but what it means for those looking for strategies to address long-standing challenges in our drug distribution system and drug discount programs.
While this report is filled with valuable data analysis and detailed policy discussions, it is first and foremost a proposal for transparent solutions that work for all stakeholders and deliver more affordable prescription drugs to patients.